Cargando…
Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis
Renal cell carcinoma (RCC) accounts for 3% of all cancer-related mortalities in adults. The risk factors for the development of RCC remain under investigation. Vascular endothelial growth factor (VEGF) is a key mediator of angiogenesis and is crucial for the development and metastasis of tumors, inc...
Autores principales: | ZHANG, YONG, LI, SHENG, XIAO, HOU-QIN, HU, ZHAO-XIONG, XU, YAN-CHENG, HUANG, QI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796421/ https://www.ncbi.nlm.nih.gov/pubmed/24137466 http://dx.doi.org/10.3892/ol.2013.1499 |
Ejemplares similares
-
Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis
por: Tang, Jingyuan, et al.
Publicado: (2017) -
Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
por: Zhou, Jia-Quan, et al.
Publicado: (2017) -
Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients
por: MA, NAN, et al.
Publicado: (2015) -
The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis
por: Wang, Jiao, et al.
Publicado: (2017) -
A meta-analysis of the vascular endothelial growth factor polymorphisms associated with the risk of pre-eclampsia
por: Duan, Weicheng, et al.
Publicado: (2020)